Current status of HIV infection: a review for non-HIV-treating physicians (Q22242613)

Europe PubMed Central

title

Current status of HIV infection: a review for non-HIV-treating physicians (English)

0 references

Bettina Knoll

1

Bettina

Knoll

1 reference

PubMed

8 February 2023

Britta Lassmann

series ordinal

2

author given names

Britta

author last names

Lassmann

1 reference

PubMed

8 February 2023

Zelalem Temesgen

series ordinal

3

author given names

Zelalem

author last names

Temesgen

1 reference

PubMed

International Journal of Dermatology

8 February 2023

language of work or name

English

0 references

publication date

18 December 2007

0 references

published in

0 references

volume

46

0 references

issue

12

0 references

page(s)

1219-1228

0 references

cites work

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Fatal tuberculous meningitis caused by immune restoration disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Estimating the proportion of patients infected with HIV who will die of comorbid diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Dermatologic manifestations of the immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Changes in causes of death and associated conditions among persons with HIV/AIDS after the introduction of highly active antiretroviral therapy in Taiwan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Two case reports of symptomatic visceral leishmaniasis in AIDS patients concomitant with immune reconstitution due to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Cytomegalovirus (CMV) Retinitis Immune Restoration Disease Occurs during Highly Active Antiretroviral Therapy–Induced Restoration of CMV‐Specific Immune Responses within a Predominant Th2 Cytokine Environment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Predicting immune reconstitution syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Molecular biology of the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Worldwide emergence of extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2007.03520.X

7 January 2021

10.1111/J.1365-4632.2007.03520.X

Identifiers

DOI

0 references